BelHealth Investment Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, BelHealth Investment Partners has acquired 3 companies.

BelHealth Investment Partners’ most common sectors for investment arehealthcare services (40%) and life science (27%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (87%) and consolidation (7%). In total, BelHealth Investment Partners has invested in 10 US states.

In the last 3 years, BelHealth Investment Partners has exited 3 companies. The Firm’s most common exit type is trade sale (67%). BelHealth Investment Partners’ largest (disclosed) exit occurred in 2021 when it sold EasyDNA for $4M.

Join Mergr to view BelHealth Investment Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity20
    • M&A Buy Activity14
    • M&A Sell Activity6
  • Total Sectors Invested 5
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 4

BelHealth Investment Partners

126 East 56th Street, 23rd Floor,
New York, New York 10022
United States
(347) 308-7011
www.belhealth.com
info@belhealth.com

BelHealth Investment Partners LLC is private equity firm focused on mid-sized healthcare companies. The Firm looks to invest $20 to $50 million per transaction and specifically targets healthcare services, healthcare products, healthcare distribution, and healthcare IT. BelHealth prefers companies with recurring revenue, high margins, diverse customers, low regulatory oversight, and modest technology risk. Prospective companies are typically profitable with at least $20-$100 million of enterprise value, $10-$100 million of revenue and $2-$10 million of EBITDA. BelHealth was formed in 2011 and is based in New York City.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products, Staffing

Target Transaction Types: Buyout (LBO, MBO, MBI), Recapitalization

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 10 100
Target EBITDA 2 10
Investment Size 20 50
Enterprise Value 20 100
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.2/yr) # 8 3 3 - - - 14
Sell (0.6/yr) # 3 - 1 - - 2 6
vol $4M $4M
  20

Most Recent M&A

Company Date Value Type
EasyDNA 2021-07-19 4M USD Add-on Acquisition
Elk Grove, California · www.easy-dna.com
Care Advantage, Inc. 2021-06-01 - Secondary Buyout
Richmond, Virginia · www.careadvantageinc.com
Gemini Bio-Products, Inc. 2018-09-14 - Buyout (LBO, MBO, MBI)
West Sacramento, California · www.gembio.com
NavaDerm Partners 2018-07-17 - Consolidation
New York, New York · www.navaderm.com
Beach House Center for Recovery 2018-06-28 - Buyout (LBO, MBO, MBI)
Juno Beach, Florida · www.beachhouserehabcenter.com
Apothecary By Design 2018-01-05 - Add-on Acquisition
Portland, Maine · www.abdrx.com
Integrated Care Physicians, Inc. 2017-08-16 - Buyout (LBO, MBO, MBI)
Tampa, Florida · www.integratedcarephysicians.com
American HealthCare Staffing Association LLC 2017-02-01 - Buyout (LBO, MBO, MBI)
Traverse City, Michigan · www.ahsa.com
Care Advantage, Inc. 2017-01-04 - Buyout (LBO, MBO, MBI)
Richmond, Virginia · www.careadvantageinc.com
AHS Staffing LLC 2016-10-17 - Buyout (LBO, MBO, MBI)
Edmond, Oklahoma · www.ahsstaffing.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Gemini Bio-Products, Inc. 2018-09-14 E.I. Spectra LLC 2019-11-11 1
West Sacramento, California · www.gembio.com Ketchum, Idaho · www.orflo.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 4 (44%) - 6 (40%) -
Life Science 3 (33%) - 4 (27%) -
Medical Products - - 2 (13%) -
Staffing 2 (22%) - 2 (13%) -
Information Technology - - 1 (7%) -
Total 9 - 15 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 9 (100%) - 15 (100%) -
  California 3 (33%) - 4 (27%) -
  Florida 2 (22%) - 2 (13%) -
  New York 1 (11%) - 2 (13%) -
  Oklahoma 1 (11%) - 1 (7%) -
  New Mexico 1 (11%) - 1 (7%) -
  Michigan 1 (11%) - 1 (7%) -
  Virginia - - 1 (7%) -
  Pennsylvania - - 1 (7%) -
  New Jersey - - 1 (7%) -
  Maine - - 1 (7%) -
Total 9 - 15 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 7 (78%) - 13 (87%) -
Consolidation 1 (11%) - 1 (7%) -
Recapitalization 1 (11%) - 1 (7%) -
Total 9 - 15 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (33%) 4M (100%)
Trade Sale 2 (33%) -
Recapitalization 1 (17%) -
Secondary Sale 1 (17%) -
Total 6 $4M

Deal Values

sell # Total
< $100M 1 $4M
TOTAL $4M
Largest EasyDNA
$4M (2021-07-19)

M&A Connections

Deals
Acquired from
Investor(s)
7%
1 (7%)
Exited to
Investor(s)
33%
2 (33%)
Strategic(s)
67%
4 (67%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

PE Assets

500M USD

Established

2011

Specialist/Generalist

Specialist

Leadership

Dennis Drislane

Co-Founder & Managing Partner

Harold Blue

Co-Founder & Managing Partner

Joseph Wynne

CFO & CAO

Inder Tallur

Senior Managing Director

Scott Lee

Senior Managing Director

 Subscribe to unlock this and 169,155
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 158K M&A Transactions
  • 165K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 57K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal